Sanofi earnings were $5.8B for the trailing 12 months ending Dec 31, 2024, with -3.4% growth year over year. The latest SNY earnings report on Dec 31, 2024 announced Q4 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SNY reported annual earnings of $5.8B, with -3.5% growth.
SNY past earnings growth
How has SNY's earnings growth performed historically?
Sanofi (NASDAQ: SNY) reported Q4 2024 earnings per share (EPS) of N/A, up N/A year over year. Total SNY earnings for the quarter were N/A. In the same quarter last year, Sanofi's earnings per share (EPS) was N/A.
As of the last Sanofi earnings report, Sanofi is currently profitable. Sanofi's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $5.79 billion, a 3.47% decrease year over year.
What was SNY's earnings growth in the past year?
As of Sanofi's earnings date in Q2 2025, Sanofi's earnings has grown -3.38% year over year. This is 370.97 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 367.59%. SNY earnings in the past year totalled $5.79 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.